Clincosm LogoSign in Get a demo

stage iv uveal melanoma ajcc v7

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Recurrent Uveal Melanoma, Stage III Uveal Melanoma AJCC v7, Stage IIIA Uveal Melanoma AJCC v7 Trial in Canada, United States

Active, not recruiting
Has Results
  • Recurrent Uveal Melanoma
  • +5 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +227 more
Mar 25, 2022

Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)

Active, not recruiting
  • Cutaneous Melanoma
  • +10 more
  • Ipilimumab
  • +4 more
  • New York, New York
  • +1 more
Aug 25, 2021

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Houston (Ipilimumab, Laboratory Biomarker Analysis,

Unknown status
Has Results
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in United States (Glembatumumab Vedotin, Laboratory Biomarker

Completed
Has Results
  • Recurrent Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Glembatumumab Vedotin
  • +2 more
  • Phoenix, Arizona
  • +24 more
Jul 30, 2020

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Iris Melanoma
  • +19 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +147 more
Jun 24, 2020

Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in France, United Kingdom, United States (Laboratory Biomarker

Completed
Has Results
  • Recurrent Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Atlanta, Georgia
  • +6 more
Feb 14, 2020

Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,

Completed
Has Results
  • Metastatic Melanoma
  • +4 more
  • Bevacizumab
  • +4 more
  • San Francisco, California
  • +12 more
Jan 7, 2020

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018